Skip to main navigation Skip to search Skip to main content

SRPK2 phosphorylates tau and mediates the cognitive defects in Alzheimer's disease

  • Yi Hong
  • , Chi Bun Chan
  • , Il Sun Kwon
  • , Xuekun Li
  • , Mingke Song
  • , Hyun Pil Lee
  • , Xia Liu
  • , Pradoldej Sompol
  • , Peng Jin
  • , Hyoung Gon Lee
  • , Shan Ping Yu
  • , Keqiang Ye

Research output: Contribution to journal › Article › peer-review

57 Scopus citations

Abstract

Serine-arginine protein kinases 2 (SRPK2) is a cell cycle-regulated kinase that phosphorylates serine/arginine domain-containing proteins and mediates pre-mRNA splicing with unclear function in neurons. Here, we show that SRPK2 phosphorylates tau on S214, suppresses tau-dependent microtubule polymerization, and inhibits axonal elongationin neurons. DepletionofSRPK2in dentate gyrus inhibits tau phosphorylation in APP/PS1 mouse and alleviates the impaired cognitive behaviors. The defective LTP in APP/PS1 mice is also improved after SRPK2 depletion. Moreover, active SRPK2isincreasedinthe cortexof APP/PS1 mice and the pathological structures of human Alzheimer's disease (AD) brain. Therefore, our study suggestsSRPK2may contributetothe formationofhyperphosphorylated tau and the pathogenesis of AD.

Original languageEnglish
Pages (from-to)17262-17272
Number of pages11
JournalJournal of Neuroscience
Volume32
Issue number48
DOIs
StatePublished - Nov 28 2012

Funding

FundersFunder number
National Institute on AgingR01AG028679
National Institute on Aging

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    ASJC Scopus subject areas

    • General Neuroscience

    Fingerprint

    Dive into the research topics of 'SRPK2 phosphorylates tau and mediates the cognitive defects in Alzheimer's disease'. Together they form a unique fingerprint.

    Cite this